INC Research Holdings, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
INC Research Holdings, Inc. | INCR - NASDAQ |
$17.00-$20.00 |
$18.50 |
$20.10 | 8.1 million | 11/7/2014 |
Goldman Sachs, Credit Suisse |
Co-Manager(s): Baird, Wells Fargo Securities, William Blair |
Health Care |
Filing(s): Filed 2014-10-06 Terms Added 2014-10-27
|
For IPO Boutique's "scale of 1 to 5" BUY rating on INC Research Holdings, Inc., and our comprehensive analysis, click "Buy Market Research".
INC Research Holdings, Inc. Quote & Chart - Click for current quote -
INCR
About INC Research Holdings, Inc. (adapted from INC Research Holdings, Inc. prospectus):
They are a leading global Contract Research Organization, or CRO, based on revenues, and are exclusively focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "INCR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved